Opaleye Management Inc. - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 53 filers reported holding ETON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,134,226
+27.1%
2,430,270
+6.4%
3.30%
+72.8%
Q2 2023$7,974,650
-5.2%
2,285,000
+4.6%
1.91%
-24.3%
Q1 2023$8,412,250
+37.5%
2,185,000
+0.7%
2.52%
+18.4%
Q4 2022$6,119,400
+15.6%
2,170,000
-13.9%
2.13%
-2.7%
Q3 2022$5,294,000
-17.9%
2,521,000
+2.4%
2.19%
-24.8%
Q2 2022$6,452,000
-37.8%
2,462,500
+3.5%
2.91%
-9.7%
Q1 2022$10,374,000
+1.4%
2,379,275
-0.2%
3.22%
+48.5%
Q4 2021$10,232,000
-34.3%
2,385,000
-22.8%
2.17%
-25.4%
Q3 2021$15,564,000
-46.9%
3,088,100
-16.4%
2.91%
-40.3%
Q2 2021$29,310,000
-0.9%
3,692,600
-8.6%
4.87%
+12.1%
Q1 2021$29,573,000
-10.0%
4,040,0000.0%4.34%
+1.3%
Q4 2020$32,845,000
+14.2%
4,040,000
+11.0%
4.29%
-23.7%
Q3 2020$28,756,000
+45.0%
3,640,0000.0%5.62%
+40.4%
Q2 2020$19,838,000
+32.9%
3,640,0000.0%4.01%
+1.3%
Q1 2020$14,924,000
+41.1%
3,640,000
+147.7%
3.96%
+90.5%
Q4 2019$10,580,000
+43.7%
1,469,456
+26.1%
2.08%
-22.0%
Q3 2019$7,363,000
-13.3%
1,165,000
+8.4%
2.66%
+2.9%
Q2 2019$8,493,000
+38.8%
1,075,000
+40.6%
2.59%
+52.8%
Q1 2019$6,118,000
+91.2%
764,773
+46.2%
1.69%
+41.9%
Q4 2018$3,200,000523,0001.19%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders